- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/22 - Benzenesulfonamido pyrazines
Patent holdings for IPC class C07D 241/22
Total number of patents in this class: 20
10-year publication summary
|
2
|
2
|
3
|
1
|
2
|
1
|
2
|
0
|
2
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1589 |
2 |
| Genzyme Corporation | 1381 |
2 |
| Sanford-Burnham Medical Research Institute | 122 |
2 |
| Shanghai Yidi Biotechnology Co., Ltd. | 12 |
2 |
| The Regents of the University of California | 21018 |
1 |
| ChemoCentryx, Inc. | 356 |
1 |
| Daewoong Pharmaceutical Co., Ltd. | 374 |
1 |
| J.B. Chemicals & Pharmaceuticals Limited | 2 |
1 |
| Kyowa Hakko Kirin Co., Ltd. | 259 |
1 |
| Merck Serono S.A. Geneva | 1 |
1 |
| New York Blood Center, Inc. | 171 |
1 |
| Pfizer Limited | 145 |
1 |
| Sanford Burnham Prebys Medical Discovery Institute | 309 |
1 |
| UChicago Argonne, LLC | 965 |
1 |
| Rheinisch Westfälische Technische Hochschule Aachen (rwth) | 30 |
1 |
| Jiangsu Yingkebeita Yiyaokeji Co. Ltd. | 1 |
1 |
| Other owners | 0 |